ClinTec Pushes into Middle East with Turkish Office
CRO ClinTec International will open an office in Istanbul, Turkey to consolidate its presence in the Middle East and North Africa region.
Archives for May 26, 2013
DISPATCHES FROM INTERPHEX
Kemwell Talks Expansion and Approvals in India and the US
At this year’s Interphex, Kemwell Biopharma spoke to Outsourcing-Pharma.com about recent expansions in both India and the US.
Ranbaxy Looks to Rebuild Quality Reputation as Daiichi Vows Legal Action
Ranbaxy Laboratories is putting all of its weight behind a quality push following its admission of manufacturing adulterated drugs, and just as its parent company Daiichi Sankyo is pursuing legal action.
Malaysia's Pharmaniaga Targets MENA Region with Saudi J-V
Pharmaniaga Berhad has set up a joint venture to manufacture pharmaceuticals in Saudi Arabia citing opportunity growth in the region as a major catalyst.
Wockhardt to Suffer Revenue Loss After FDA Import Alert
Generic firm Wockhardt has received a US import alert from for all drugs from its Indian plant.
Executives: CROs Need to Be Less ‘Passive’ in Partnerships with Sponsors
Pharma and CRO executives have said that CROs could do more to be proactive in their partnerships, though some CRO executives believe that can be difficult because of the varying nature of their clients.
EMA Updates Inspector Expectations for API Audits
As new API regulations are set in July for those outside the EU, the European Medicines Agency (EMA) has unveiled what its inspectors expect to see from API manufacturer or supplier audit reports from inside the region.